Recent News and Updates
“Father of Tamoxifen” Dr V. Craig Jordan supports a recent case report by our Dr. Lemmo. There may exist a potential “dark-side” of Tamoxifen-type drugs used in breast cancer and its prevention.
A patient with advanced breast cancer experienced a significant shrinkage of her metastatic disease when stopping the drug Raloxifene (a relative of Tamoxifen). She continues to be in excellent shape without the need of any treatment during the past 16 months. The oncology community is largely not aware of this phenomenon where a drug designed to help with breast cancer may do the exact opposite and feed the disease. Senior scientist and researcher Dr. V. Craig Jordan from MD Anderson Cancer Center in Texas wanted to place further attention in this area by writing an editorial on our case. This has been such an incredible honour and we are truly humbled by Dr. Jordan’s supportive comments.
To find out more, the scientific article can be found below.
45th Annual International Conference – Orthomolecular Medicine Today in Vancouver – April 29 – May 1 2016
Dr Lemmo will be speaking on the use of intravenous vitamin C plus some promising technologies in cancer here in Vancouver at the Fairmont Hotel Vancouver on April 30, 2016. Please find out more in the attached brochure.OMT-2016
Dr. Rogers Prize Award Gala 2015
Early bird tickets now on sale at the below website